NADAL® Lyme Borreliosis IgG/IgM test cassette


10 individually packed test cassettes for detection of human IgG and IgM to European strains of Borrelia in human serum and


Package contents:

10 Test cassettes

10 disposable pipettes

1 buffer bottle

1 package insert




Exclusively for professional users

Discover more than 2,000 medical and toxicological tests and POCT solutions

Please note: The prices shown are basic list prices. Your individual prices will be displayed after you have logged in to the shop. Your personal customer advisors can add them at any time.

Sign in/Register

We are at your service under the following contact options:
+49 (0)941-29010-0 or info(at)

Or simply use our contact form

Product description

The NADAL® Lyme Borreliosis IgG/IgM Test is a rapid qualitative screening test for the detection of human IgG and IgM to European strains of Borrelia in human serum and
plasma. The test is intended for use as an aid in the diagnosis of Lyme disease, also known as Lyme borreliosis, and is designed for professional use only. However, in the case of a positive result, the NADAL® Lyme Borreliosis IgG/IgM Test does not enable the stage of the disease to be determined.

Lyme disease or Lyme borreliosis is caused by the spirochete Borrelia burgdorferi sensu lato, which is transmitted by ticks. Contagious ticks, infected by Borrelia
burgdorferi sensu lato, are mainly found in North America (Ixodes scapularis or Ixodes pacificus) and in temperate areas of Western Europe (Ixodes ricinus). European tick species are vectors of European Borrelia strains, such as B. burgdorferi sensu stricto, B. afzelii, B. garinii  as well as B. spielmanii and B bavariensis, which are also known to be pathogenic.
B. valaisiana and B. lusitaniae are also considered to be potentially pathogenic strains. Due to the high similarity amongst Borrelia strains, IgG and IgM directed against different Borrelia species cross-react with the antigen cocktail of the NADAL® Lyme Borreliosis IgG/IgM Test - at least in the case of European strains.
In 30% to 80% of cases, a skin rash (erythema chronicum migrans) is the first clinical sign of the infection, appearing after 3 to 10 days at the site of the tick bite. Between 1 and 3
months later, the first neurological signs, such as a headache or severe disorders like myelitis, appear - even in the absence of erythema chronicum migrans. Patients may also develop severe complications, such as intermittent attacks of articular arthritis, myocarditis or acrodermatitis much later, even several years after the primary infection.

More Information

More Information
SKU 870001N-10
Testformat test cassette
Test evaluation Provides a qualitative test result
Sample type Serum, Plasma
Detected parameter Lyme Borreliosis IgG/IgM
Package size 10 individually packed test cassettes
Detection time Test result after 10 minutes
Storage temperature The test should be stored at 4 - 30 °C
CE-Label Yes
Pathogentype Bacterial infection


No files available.


No files available.

Copyright @2023 nal von minden GmbH. All rights reserved.